Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.340
-0.040 (-2.90%)
At close: Mar 18, 2026, 4:00 PM EDT
1.288
-0.052 (-3.88%)
After-hours: Mar 18, 2026, 4:52 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $61.45 million as of March 18, 2026. Its market cap has decreased by -15.74% in one year.
Market Cap
61.45M
Enterprise Value
56.30M
1-Year Change
-15.74%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.77M to $61.45M, a decrease of -14.38%. That is a compound annual growth rate of -1.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 61.45M | -30.93% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grace Therapeutics | 68.86M |
| XBiotech | 68.60M |
| Actuate Therapeutics | 64.38M |
| ImageneBio | 64.14M |
| Fractyl Health | 62.93M |
| Alterity Therapeutics | 62.53M |
| Coeptis Therapeutics Holdings | 62.48M |
| TScan Therapeutics | 62.02M |